How ketamine therapy works for depression, anxiety, and PTSD

Ketamine produces relief faster than any traditional antidepressant — often within hours of a single infusion. It does this by triggering a rapid surge in synaptic plasticity: new neural connections form, rigid thought patterns soften, and the brain becomes genuinely receptive to change. Peer-reviewed research confirms this mechanism involves NMDA receptor modulation and activation of BDNF and mTOR signaling — the same pathways responsible for learning, memory, and emotional regulation.

That neuroplastic window is real — but it is also brief. Without structured therapeutic support in the days following treatment, the brain tends to return to its familiar patterns. Integration therapy is what keeps that window open long enough to matter.

Who is ketamine integration therapy for?

If you have tried antidepressants, talk therapy, or other treatments without lasting relief, you are not alone — and you are exactly who ketamine-assisted care at Clarus Health is designed for. Treatment-resistant depression affects an estimated one-third of people with major depressive disorder, according to the National Institute of Mental Health. PTSD and anxiety disorders are similarly undertreated by conventional medication alone.

For patients dealing with addiction and substance use, the evidence is particularly compelling: a phase 2 randomized controlled trial found that ketamine combined with psychological therapy produced significantly better abstinence outcomes at six months than ketamine without it. The therapy component was not incidental — it was the difference.

The common thread across all of these conditions is that the medicine alone is not enough. The therapeutic relationship, the preparation, and the integration work are what convert a biochemical event into a lasting shift.

Does ketamine integration therapy work? What the research shows

The evidence base is growing rapidly. A systematic review evaluating 19 studies and over 1,000 patients concluded that the combination of ketamine and psychotherapy offers significant promise across multiple psychiatric disorders. A large effectiveness study found that patients who received ketamine-assisted therapy with structured integration showed sustained reductions in depression, anxiety, and PTSD at both 3 and 6 months — well beyond the last session.

This integration framework draws on the same preparation-and-processing model validated in phase 3 psychedelic-assisted therapy clinical trials, where structured integrative sessions were a core component of treatment protocol — not optional aftercare.

Ketamine integration therapy in San Francisco

At Clarus Health, integration therapy is not an add-on — it is built into how we deliver IV ketamine and Spravato care from the start. Our holistic psychiatry team works with you before your session to set intentions and optimize your medications, and with you afterward to process what emerged and anchor it into real, lasting change. Because your prescribing and therapeutic care are held by the same team, nothing falls through the cracks between providers.

This is whole-person psychiatric care — combining the rapid neurobiological effects of ketamine and Spravato with the depth of therapeutic support that makes those effects stick. If you are navigating depression, anxiety, PTSD, or addiction and have not found lasting relief, this is where that changes.